+

WO2002063044A3 - Haplotypes du gene il15 - Google Patents

Haplotypes du gene il15 Download PDF

Info

Publication number
WO2002063044A3
WO2002063044A3 PCT/US2001/025470 US0125470W WO02063044A3 WO 2002063044 A3 WO2002063044 A3 WO 2002063044A3 US 0125470 W US0125470 W US 0125470W WO 02063044 A3 WO02063044 A3 WO 02063044A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
haplotypes
disclosed
haplotyping
genotyping
Prior art date
Application number
PCT/US2001/025470
Other languages
English (en)
Other versions
WO2002063044A2 (fr
Inventor
Alison E Anastasio
Anne Chew
R Rex Denton
Krishnan Nandabalan
J Claiborne Stephens
Charles Tirrell
Original Assignee
Genaissance Pharmaceuticals
Alison E Anastasio
Anne Chew
R Rex Denton
Krishnan Nandabalan
J Claiborne Stephens
Charles Tirrell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2001/004130 external-priority patent/WO2001058914A2/fr
Application filed by Genaissance Pharmaceuticals, Alison E Anastasio, Anne Chew, R Rex Denton, Krishnan Nandabalan, J Claiborne Stephens, Charles Tirrell filed Critical Genaissance Pharmaceuticals
Publication of WO2002063044A2 publication Critical patent/WO2002063044A2/fr
Publication of WO2002063044A3 publication Critical patent/WO2002063044A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouvelles variantes génétiques du gène de l'interleukine 15 (IL 15). L'invention concerne divers génotypes, haplotypes, et paires d'haplotypes qui existent dans la population des Etats-Unis pour le gène Il 15. L'invention concerne également des compositions et des méthodes d'haplotypage et/ou de génotypage du gène IL15 chez un individu. L'invention concerne enfin des polynucléotides définis par lesdits haplotypes.
PCT/US2001/025470 2001-02-08 2001-08-15 Haplotypes du gene il15 WO2002063044A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2001/004130 WO2001058914A2 (fr) 2000-02-08 2001-02-08 Haplotypes du gene de l'interleukine 15
USPCT/US01/04130 2001-02-08

Publications (2)

Publication Number Publication Date
WO2002063044A2 WO2002063044A2 (fr) 2002-08-15
WO2002063044A3 true WO2002063044A3 (fr) 2004-02-26

Family

ID=21742326

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/025470 WO2002063044A2 (fr) 2001-02-08 2001-08-15 Haplotypes du gene il15

Country Status (1)

Country Link
WO (1) WO2002063044A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925626A1 (fr) 2003-07-21 2008-05-28 Transgene S.A. Nouvelles cytokines multifonctionnelles

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972614A (en) * 1995-12-06 1999-10-26 Genaissance Pharmaceuticals Genome anthologies for harvesting gene variants
WO2001058914A2 (fr) * 2000-02-08 2001-08-16 Genaissance Pharmaceuticals, Inc. Haplotypes du gene de l'interleukine 15
WO2001080156A1 (fr) * 2000-04-18 2001-10-25 Genaissance Pharmaceuticals, Inc. Procede et systeme de determination d'haplotypes a partir d'une recueil de polymorphismes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972614A (en) * 1995-12-06 1999-10-26 Genaissance Pharmaceuticals Genome anthologies for harvesting gene variants
WO2001058914A2 (fr) * 2000-02-08 2001-08-16 Genaissance Pharmaceuticals, Inc. Haplotypes du gene de l'interleukine 15
WO2001080156A1 (fr) * 2000-04-18 2001-10-25 Genaissance Pharmaceuticals, Inc. Procede et systeme de determination d'haplotypes a partir d'une recueil de polymorphismes

Non-Patent Citations (16)

* Cited by examiner, † Cited by third party
Title
[online] "SNP", XP002229429, retrieved from DBSNP/NCBI Database accession no. rs1493012 *
[online] "SNP", XP002229430, retrieved from DBSNP/NCBI Database accession no. rs1493013 *
[online] 12 September 2000 (2000-09-12), BENNETT AND COWSERT: ""Antisense inhibition of interleukin-15 expression", XP002213638, retrieved from EBI Database accession no. AR087016 *
BADER J S: "THE RELATIVE POWER OF SNPS AND HAPLOTYPE AS GENETIC MARKERS FOR ASSOCIATION TESTS", PHARMACOGENOMICS, ASHLEY PUBLICATIONS, GB, vol. 2, no. 1, February 2001 (2001-02-01), pages 11 - 24, XP009002043, ISSN: 1462-2416 *
BIDWELL J L ET AL: "HUMAN CYTOKINE GENE NUCLEOTIDE SEQUENCE ALIGNMENTS, 1998", EUROPEAN JOURNAL OF IMMUNOGENETICS, OXFORD, GB, vol. 2/3, no. 25, April 1998 (1998-04-01), pages 83 - 265, XP001094797, ISSN: 0960-7420 *
CLAIBORNE STEPHENS J: "SINGLE-NUCLEOTIDE POLYMORPHISMS, HAPLOTYPES AND THEIR RELEVANCE TO PHARMACOGENTICS", MOLECULAR DIAGNOSIS, NAPERVILLE, IL, US, vol. 4, no. 4, 1999, pages 309 - 317, XP002937520, ISSN: 1084-8592 *
CLARK A G ET AL: "HAPLOTYPE STRUCTURE AND POPULATION GENETIC INFERENCES FROM NUCLEOTIDE- SEQUENCE VARIATION IN HUMAN LIPOPROTEIN LIPASE", AMERICAN JOURNAL OF HUMAN GENETICS, UNIVERSITY OF CHICAGO PRESS, CHICAGO,, US, vol. 63, 1998, pages 595 - 612, XP002937239, ISSN: 0002-9297 *
DRYSDALE C M ET AL: "Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. UNITED STATES 12 SEP 2000, vol. 97, no. 19, 12 September 2000 (2000-09-12), pages 10483 - 10488, XP002213210, ISSN: 0027-8424 *
JUDSON R ET AL: "NOTES FROM THE SNP VS. HAPLOTYPE FRONT", PHARMACOGENOMICS, ASHLEY PUBLICATIONS, GB, vol. 2, no. 1, 2001, pages 1 - 7, XP008009453, ISSN: 1462-2416 *
JUDSON R ET AL: "The predictive power of haplotypes in clinical response.", PHARMACOGENOMICS. ENGLAND FEB 2000, vol. 1, no. 1, February 2000 (2000-02-01), pages 15 - 26, XP002213209, ISSN: 1462-2416 *
KRAUSE H ET AL: "GENOMIC STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN INTERLEUKIN 15 GENE (IL-15)", CYTOKINE, ACADEMIC PRESS LTD, PHILADELPHIA, PA, US, vol. 8, no. 9, September 1996 (1996-09-01), pages 667 - 674, XP002946159, ISSN: 1043-4666 *
OESTREICHER P: "4th Annual Pharmacogenomics and Medicine Lectures.", PHARMACOGENOMICS. ENGLAND AUG 2001, vol. 2, no. 3, April 2001 (2001-04-01), pages 291 - 296, XP002229261, ISSN: 1462-2416 *
RUANO G ET AL: "GENOTYPING AND HAPLOTYPING OF POLYMORPHISMS DIRECTLY FROM GENOMIC DNA VIA COUPLED AMPLIFICATION AND SEQUENCING (CAS)", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 19, no. 24, 1991, pages 6877 - 6882, XP000197814, ISSN: 0305-1048 *
RUANO: "Genaissance Awarded Broad Patent On Methods For Collecting Genes For Variation Analysis Across Populations", GENAISSANCE PRESS RELEASE, 8 November 1999 (1999-11-08), XP002229209, Retrieved from the Internet <URL:WWW.biomedicine.ch/publications/genaissance/g111199.html> [retrieved on 20030226] *
STEPHENS J C ET AL: "Haplotype variation and linkage disequilibrium in 313 human genes.", SCIENCE. UNITED STATES 20 JUL 2001, vol. 293, no. 5529, 20 July 2001 (2001-07-20), pages 489 - 493, XP002229260, ISSN: 0036-8075 *
ULBRECHT M ET AL: "Assoziation of beta 2-adrenoreceptor variants with bronchial hyperresponsiveness", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMERICAN LUNG ASSOCIATION, NEW YORK, NY, US, vol. 161, no. 2, February 2000 (2000-02-01), pages 469 - 474, XP002188594, ISSN: 1073-449X *

Also Published As

Publication number Publication date
WO2002063044A2 (fr) 2002-08-15

Similar Documents

Publication Publication Date Title
WO2002026768A3 (fr) Haplotypes du gene por
WO2002038589A3 (fr) Haplotypes du gene cyp2d6
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2002063044A3 (fr) Haplotypes du gene il15
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002062820A3 (fr) Haplotypes du gene cyp27b1
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002046209A3 (fr) Haplotypes du gene cyp3a5
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2002042320A3 (fr) Haplotypes du gene de glutathione reductase
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2002012561A3 (fr) Haplotypes du gene or1g1
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2001090118A3 (fr) Haplotypes du gene edn2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载